Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic LeukemiaCooper Quartermaine, Daniel Addison, Onaopepo Kola‐Kehinde et al.|JACC CardioOncology|2023Cited by 107
Ventricular arrhythmias and sudden death events following acalabrutinib initiationSeema A. Bhat, Daniel Addison, John C. Byrd et al.|Blood|2022Cited by 68
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiationSunnia T. Chen, Daniel Addison, Sujay Kalathoor et al.|Journal of Hematology & Oncology|2022Cited by 36
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated CardiotoxicityBenjamin Buck, Daniel Addison, John C. Byrd et al.|JAMA Oncology|2023Cited by 29